The GNAS Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji human B lymphoblastoid cell line, engineered for targeted disruption of the GNAS gene. This loss-of-function model eliminates expression of the Gs?? subunit of heterotrimeric G proteins, enabling precise interrogation of Gs??-dependent signaling networks in a B-cell context. The polyclonal nature provides a heterogeneous knockout population, reflecting a range of editing outcomes without clonal selection, suitable for pooled functional studies. This product is an essential tool for dissecting cAMP-mediated pathways in immune and cancer biology, particularly within the framework of GPCR signal transduction.
The Raji host cell line is a well-characterized B lymphoblastoid model established from a Burkitt lymphoma patient, distinguished by its Epstein-Barr virus (EBV)-positive status and absence of surface immunoglobulin expression. These cells retain key features of B lymphocytes, including expression of various G protein-coupled receptors (GPCRs) and intact downstream signaling machinery, making them a robust platform for studying lymphocyte activation, proliferation, and apoptosis. The EBV-driven immortalization confers stable propagation in culture, while the Burkitt lymphoma origin provides a clinically relevant background for oncogenic signaling research, particularly involving the cAMP and MAPK/ERK pathways.
GNAS encodes the stimulatory G protein alpha subunit (Gs??), a critical transducer that couples activated GPCRs to adenylyl cyclase (ADCY) to catalyze cAMP production. Downstream, cAMP activates protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac), leading to phosphorylation of transcription factors such as CREB and modulation of ERK1/2 and AKT pathways. Key upstream regulators include the beta-adrenergic receptors ADRB1 and ADRB2, thyroid-stimulating hormone receptor (TSHR), and parathyroid hormone 1 receptor (PTH1R). Gs?? interacts with G?¦? dimers (GNB1, GNG2), regulator of G protein signaling (RGS) proteins, A-kinase anchoring protein 5 (AKAP5), and caveolin-1 (CAV1) to orchestrate signaling specificity. The canonical pathway proceeds from GPCR via Gs?? to adenylyl cyclase, elevating cAMP, which activates PKA and subsequently phosphorylates CREB, driving transcriptional responses. Additionally, Gs?? can engage SRC kinase to stimulate ERK signaling, highlighting its multifaceted role in cellular regulation.
In Raji cells, GNAS knockout abrogates Gs?? protein function, directly impairing GPCR-stimulated cAMP synthesis and disrupting PKA-CREB-mediated gene expression. This perturbation affects critical B-cell processes, including proliferation, apoptosis, and immune signaling, given the reliance of lymphocyte activation on cAMP dynamics. The model is particularly valuable for exploring the role of Gs?? in Burkitt lymphoma pathogenesis, where aberrant GPCR and cAMP signaling contribute to oncogenic transformation. Furthermore, it enables study of endocrine-related signaling in a B-cell context, linking GNAS mutations to conditions such as McCune-Albright syndrome, pseudohypoparathyroidism type 1a, and pituitary adenomas, where constitutively active or deficient Gs?? alters hormone responsiveness.
This polyclonal knockout model is ideally suited for a wide range of functional assays. Researchers can validate Gs?? loss by Western blot and measure downstream effects via cAMP ELISA, PKA activity assays, and phospho-CREB flow cytometry. Functional consequences on cell proliferation and apoptosis are readily assessed by MTS and Annexin V/PI staining, respectively. Transcriptomic profiling using RNA-seq provides a global view of GNAS-dependent gene expression changes. Application areas include dissecting GPCR-Gs??-cAMP signaling in B-cell physiology, investigating the role of GNAS in lymphoma progression, and screening small molecules that modulate cAMP levels or downstream effectors. For further information or to inquire about custom knockout services, contact Ascent Research.
